Go Pro
→ This loan shouldn't be possible (From Behind the Markets) (Ad)tc pixel Free VCKAW Stock Alerts

Vickers Vantage Corp. I (VCKAW) Competitors

$0.17 0.00 (0.00%)
As of 08/14/2026
Compare

VCKAW vs. SXTPW, BFRIW, CALA, CINGW, and CMRAW

Should you buy Vickers Vantage Corp. I stock or one of its competitors? Vickers Vantage Corp. I's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Calithera Biosciences (CALA), Cingulate (CINGW), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Vickers Vantage Corp. I compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Vickers Vantage Corp. I (NASDAQ:VCKAW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

In the previous week, 60 Degrees Pharmaceuticals had 2 more articles in the media than Vickers Vantage Corp. I. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Vickers Vantage Corp. I. 60 Degrees Pharmaceuticals' average media sentiment score of 1.93 beat Vickers Vantage Corp. I's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Very Positive
Vickers Vantage Corp. I Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
Vickers Vantage Corp. IN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Vickers Vantage Corp. I N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats Vickers Vantage Corp. I on 3 of the 3 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Biofrontera?

Vickers Vantage Corp. I (NASDAQ:VCKAW) and Biofrontera (NASDAQ:BFRIW) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

Company Net Margins Return on Equity Return on Assets
Vickers Vantage Corp. IN/A N/A N/A
Biofrontera N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vickers Vantage Corp. IN/AN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

In the previous week, Biofrontera had 3 more articles in the media than Vickers Vantage Corp. I. MarketBeat recorded 3 mentions for Biofrontera and 0 mentions for Vickers Vantage Corp. I. Biofrontera's average media sentiment score of 0.96 beat Vickers Vantage Corp. I's score of 0.00 indicating that Biofrontera is being referred to more favorably in the news media.

Company Overall Sentiment
Vickers Vantage Corp. I Neutral
Biofrontera Positive

Summary

Biofrontera beats Vickers Vantage Corp. I on 3 of the 3 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Calithera Biosciences?

Vickers Vantage Corp. I (NASDAQ:VCKAW) and Calithera Biosciences (NASDAQ:CALA) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vickers Vantage Corp. IN/AN/AN/AN/AN/A
Calithera BiosciencesN/AN/A-$39.65MN/AN/A

In the previous week, Calithera Biosciences had 1 more articles in the media than Vickers Vantage Corp. I. MarketBeat recorded 1 mentions for Calithera Biosciences and 0 mentions for Vickers Vantage Corp. I. Vickers Vantage Corp. I's average media sentiment score of 0.00 equaled Calithera Biosciences'average media sentiment score.

Company Overall Sentiment
Vickers Vantage Corp. I Neutral
Calithera Biosciences Neutral

Company Net Margins Return on Equity Return on Assets
Vickers Vantage Corp. IN/A N/A N/A
Calithera Biosciences N/A N/A N/A

Summary

Calithera Biosciences beats Vickers Vantage Corp. I on 1 of the 1 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Cingulate?

Vickers Vantage Corp. I (NASDAQ:VCKAW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

Company Net Margins Return on Equity Return on Assets
Vickers Vantage Corp. IN/A N/A N/A
Cingulate N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vickers Vantage Corp. IN/AN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

In the previous week, Cingulate had 2 more articles in the media than Vickers Vantage Corp. I. MarketBeat recorded 2 mentions for Cingulate and 0 mentions for Vickers Vantage Corp. I. Cingulate's average media sentiment score of 1.44 beat Vickers Vantage Corp. I's score of 0.00 indicating that Cingulate is being referred to more favorably in the news media.

Company Overall Sentiment
Vickers Vantage Corp. I Neutral
Cingulate Positive

Summary

Cingulate beats Vickers Vantage Corp. I on 2 of the 2 factors compared between the two stocks.

How does Vickers Vantage Corp. I compare to Comera Life Sciences?

Vickers Vantage Corp. I (NASDAQ:VCKAW) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Company Net Margins Return on Equity Return on Assets
Vickers Vantage Corp. IN/A N/A N/A
Comera Life Sciences N/A N/A N/A

In the previous week, Vickers Vantage Corp. I's average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score.

Company Overall Sentiment
Vickers Vantage Corp. I Neutral
Comera Life Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vickers Vantage Corp. IN/AN/AN/AN/AN/A
Comera Life Sciences$1.00MN/AN/AN/AN/A

Summary

Comera Life Sciences beats Vickers Vantage Corp. I on 1 of the 1 factors compared between the two stocks.

Get Vickers Vantage Corp. I News Delivered to You Automatically

Sign up to receive the latest news and ratings for VCKAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VCKAW vs. The Competition

Export
MetricVickers Vantage Corp. IPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$11.83B$7.03B$13.06B
Dividend YieldN/A2.69%2.56%10.62%
P/E RatioN/A779.61270.8525.39
Price / SalesN/A745.10606.4591.90
Price / CashN/A15.0328.8738.47
Price / BookN/A10.4011.096.51
Net IncomeN/A$2.78B$3.45B$347.22M
7 Day PerformanceN/A0.99%0.62%1.27%
1 Month Performance-16.83%0.21%2.09%2.72%
1 Year Performance-62.12%144.06%61.58%21.85%

Vickers Vantage Corp. I Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VCKAW
Vickers Vantage Corp. I
N/A$0.17
flat		N/A-62.1%$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat		N/A-67.7%$0.00$1.00MN/A2
BFRIW
Biofrontera
N/A$0.03
+7.2%		N/A-75.2%$0.00$43.20MN/A70
CALA
Calithera Biosciences
N/AN/AN/AN/A$0.00N/AN/A60
CINGW
Cingulate
N/A$0.01
-6.1%		N/A-85.7%$0.00N/AN/A20

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:VCKAW) was last updated on 8/18/2026 by MarketBeat.com Staff.
From Our Partners
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
Iran War: What Happened at 1:11 P.M. Outside D.C.?
A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 t...
Banyan Hill Publishing | Sponsoredtc pixel
A Dark Day Is Coming to America
Keith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift...
TradeSmith | Sponsoredtc pixel
Gold Miners Post Record Cash Flow Even as Prices Pull Back
The four largest gold miners are generating record free cash flow, even with gold pulling back from recent hig...
Golden Portfolio | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
NVIDIA Is 27X Bigger Than One of His "Price Killers"
A little-known company has quietly built a proprietary machine-learning platform trained on 15 years of data f...
The Oxford Club | Sponsoredtc pixel
Someone just dumped the biggest gold fund.
Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...
Behind the Markets | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel